ActivePure’s Advanced Photohydrolysis Technology Demonstrates Rapid Inactivation of SARS-CoV-2, RSV, and Monkeypox Virus in Aerosolized Form
A new brief report published in the American Journal of Infection Control (AJIC) demonstrates that ActivePure’s Advanced Photohydrolysis (AP) Technology effectively and rapidly inactivates aerosolized SARS-CoV-2, respiratory syncytial virus (RSV), and monkeypox virus (MPXV). The study highlights AP’s potential as a valuable tool for improving indoor air quality and infection control, particularly in high-risk settings.
